OCGNOcugen, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 19539
Ticker: OCGN
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2014-12-03
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: OCGN

Detail

Enriched 2026-08-14 20:47

Market cap: $474,754,561.4
Shares outstanding (class): 339,110,401
Shares outstanding (weighted): 339,110,401
SIC: 2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees: 116
Location: MALVERN, PA
Homepage: https://www.ocugen.com
Description: Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

Market cap and share counts drift.

Funds holding this security

15 funds · 16 positions · $40.50M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$17.74M	0.00%	9,801,994 NS	FIGI
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST	XBI	$9.45M	0.13%	5,222,819 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$6.63M	0.01%	3,665,453 NS	FIGI
State Street(R) SPDR(R) S&P Kensho New Economie… SPDR SERIES TRUST	KOMP	$4.62M	0.20%	2,554,326 NS	FIGI
iShares Core S&P Total U.S. Stock Market ETF iShares Trust	ITOT	$1.17M	0.00%	645,821 NS	FIGI
VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS	—	$339.4K	0.00%	187,541 NS	FIGI
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX… VANGUARD INSTITUTIONAL INDEX FUNDS	—	$266.1K	0.00%	146,991 NS	FIGI
Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST	—	$142.2K	0.00%	78,538 NS	FIGI
PROFUND VP BIOTECHNOLOGY ProFunds	—	$52.6K	0.13%	29,074 NS	FIGI
VIP Extended Market Index Portfolio Variable Insurance Products Fund II	—	$39.9K	0.01%	22,064 NS	FIGI
VIP Total Market Index Portfolio Variable Insurance Products Fund II	—	$13.5K	0.00%	7,448 NS	FIGI
Total Stock Market Index Trust John Hancock Variable Insurance Trust	—	$9.6K	0.00%	5,289 NS	FIGI
Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds	—	$8.9K	0.00%	4,900 NS	FIGI
State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST	—	$6.2K	0.00%	3,448 NS	FIGI
BlackRock Small Cap Index V.I. Fund BlackRock Variable Series Funds, Inc.	—	$2.5K	0.00%	1,394 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKEROCGN
FIGI_COMPOSITEBBG00194VJB1
FIGI_SHARE_CLASSBBG001TG1LS2
CIK0001372299
ISINUS67577C1053
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Ocugen is a biopharmaceutical company focused on developing gene therapies and vaccines, fitting the biotechnology industry.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.